ArticleExperimental & molecular medicine2023

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer.

Dong Hoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.